The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKendrick Resources Regulatory News (KEN)

Share Price Information for Kendrick Resources (KEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.425
Bid: 0.30
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.25 (83.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.35
KEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding Facility

22 Apr 2024 07:00

RNS Number : 4160L
Kendrick Resources PLC
22 April 2024
 

22 April 2024

 

Kendrick Resources Plc("Kendrick" or the "Company")

  Funding Facility

 

Kendrick Resources Plc (LSE: KEN), the mineral exploration and development company building vanadium, nickel and copper battery metal projects in Scandinavia is pleased to announce that the Company has entered into an unsecured convertible loan funding facility (the "Facility") for £500,000 with Sanderson Capital Partners Ltd (the "Lender"), a long term shareholder in the Company. The Facility is convertible at 0.75 pence per ordinary share ("Shares") and can be drawn down in 4 tranches of £125,000 each ("Loan Tranches"). The Facility is a standby facility as a potential additional source of working capital for the Company in a period when the funding market for junior exploration companies is subject to market volatility.

 

Working Capital Facility Agreement

The Facility is for £500,000 in total, is unsecured, interest free and can be drawn down in four tranches as follows:

· £125,000 to be drawn down within 6 months of 7 May 2024 ("Tranche One");

· £125,000 to be drawn down within 6 months of 7 July 2024 ("Tranche Two");

· £125,000 to be drawn down within 6 months of 7 September 2024 ("Tranche Three"); and

· £125,000 to be drawn down within 6 months of 7 November 2024 ("Tranche Four")

 

The Company will provide a Loan drawdown notice if and when it requires a drawdown. The Company has the option but not the obligation to drawdown on part or all of the Facility.

 

Repayment and Conversion

Repayment

Unless otherwise converted, the Company must repay each Loan Tranche on the first anniversary of the advance by the Lender of the applicable Loan Tranche ("Maturity Date"). The Company may prepay the whole or part of the Facility on any day prior to the Maturity Date for a Loan Tranche upon giving not less than 14 days' prior written notice to the Lender and paying in cash a prepayment fee of 5% of the amount which the Company prepays in cash before the Maturity Date. The Lender can during the 14 days' notice period make an election for all or part of the Loan subject to a prepayment notice to be repaid in Shares in which case the 5% fee shall not apply to that proportion of the Loan repaid in Shares.

 

Conversion of Loan Tranche by Lender

The Lender may at any time during the Facility Period elect to convert all or part of any drawn down amount into such number of new Shares equal to the amount of the Loan Tranche that is to be repaid at the date of the election, divided by the 0.75 pence ("Conversion Price") (the "Conversion Shares"). The Conversion Price of 0.75 pence per Share represents a 87% premium to the closing share price of 0.4 pence on 19 April 2024, being the latest practicable date prior to this announcement.

 

Conversion of Loan by the Company

The Company may at any time during the Loan Period elect to convert all or part of Tranche One to Tranche Four if the Share price exceeds 1 pence ("Target Conversion Price") for a period of five or more business days.

 

Conversion Adjustment

If the Company before i) the Maturity Date for a Loan Tranche and before ii) the Loan Tranche has been repaid issues Shares for cash consideration ("Issue Price") at a discount to 0.75 pence per Share (the "Base Issue Price") then the Conversion Price and the Target Conversion Price in respect of that Loan Tranche shall be multiplied by a fraction, the numerator of which will be the Issue Price and the denominator of which will be 0.75 pence.

 

Interest and Fees

The Loan is interest free. The Lender shall be paid an arrangement fee of 10% of the amount of the Facility to be settled by the issue of 11,764,706 new Shares ("Facility Fee Shares") credited as fully paid by at an issue price of 0.425p per Share (being the Five Day VWAP on the date of this announcement) with the Facility Fee Shares to be issued on or before 31 December 2024 or such other date agreed by the parties

 

On the drawdown of any Loan Tranche the Lender shall be paid a further fee of 2% of the amount of the relevant Loan Tranche which is to be settled by the issue of new Shares credited as fully paid at the five-day VWAP on the date of the relevant Loan drawdown notice ("Drawdown Fee Shares") with the Drawdown Fee Shares to be issued on or before 31 December 2024 or such other date agreed by the parties

 

Option to Extend Facility

If the Company draws down in full or in part against Tranche One, Tranche Two, Tranche Three and Tranche Four then it has the option to elect to be able to drawdown up to an additional GBP250,000 ("Optional Loan Tranche") This must be made in writing within 30 days of the date the Company has made a drawdown in full or in part against Tranche One, Tranche Two, Tranche Three and Tranche Four. 

 

Warrants

On the drawdown of any Loan Tranche, the Lender shall be issued three year warrants over Shares ("Warrants") with a face value equal to 50% of the amount drawn down under the Loan Tranche. The exercise price for the Warrants applicable to each of the tranches are as follows:

 

· 1.5 pence per share for the drawdown of Tranche One to Tranche Four; and

· 2 pence per share for the drawdown of the Optional Loan Tranche;

 

If there are no drawdowns under two or more of the Loan Tranches then at 7 May 2025 which is 6 months after the Tranche Four Drawdown Date of 7 November 2024, the Company will issue a three year warrant to the Lender for an amount equal to 25% of the Facility that has not been drawn down with an exercise price of 1 pence per share.

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).

For additional information please contact:

 

Kendrick Resources Plc:

Chairman

 

Tel: +44 2039 616 086

Colin Bird

Novum Securities

Financial Adviser

Joint Broker

Tel: +44 207 399 9400

David Coffman / George Duxberry

Jon Bellis

 

Shard Capital Partners LLP

Joint Broker

Tel: +44 207 186 9952

Damon Heath / Isabella Pierre

 

 

 

About Kendrick Resources Plc

Kendrick Resources Plc is a mineral exploration and development company with projects primarily based across Scandinavia. The principle of its business is to explore the opportunities within the natural resources sector with a focus on battery, base, and precious metals including but not limited to vanadium and nickel. In doing so, the Company is looking to build a long term energy metals business in Scandinavia which delivers energy metals to Europe to help enable its renewable energy transformation by building a top tier energy metals production business.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODFLFSTSSILFIS
12
Date   Source Headline
29th Apr 20246:16 pmRNSFinal Results
22nd Apr 20247:00 amRNSFunding Facility
8th Feb 20247:00 amRNSAirijoki Drill Results
7th Feb 20247:00 amRNSEspedalen Update
12th Oct 20237:00 amRNSCompletion of Airijoki Extension Drill program
29th Sep 20237:00 amRNSInterim Results for the Six Months to 30 June 2023
21st Aug 20237:00 amRNSOperational Update
7th Aug 20237:00 amRNSAcquisition of New Licences
27th Jul 20233:42 pmRNSSupplemental Notice of Annual General Meeting
11th Jul 20239:43 amRNSSupplemental Notice of Annual General Meeting
5th Jul 20237:00 amRNSNotice of AGM
24th May 20237:00 amRNSStormyra Final Batch Assay Results
4th May 20237:00 amRNSStormyra Second Batch Assay Results, Maiden Drill
28th Apr 20235:33 pmRNSFinal Results for period to 31 December 2022
28th Apr 20237:00 amRNSTotal Voting Rights
24th Apr 202312:19 pmRNSUpdate on issue of equity to EMX
20th Apr 20231:33 pmRNSExercise of Options and Issue of Equity
20th Apr 20231:13 pmRNSEspedalen Update and Assay Results
29th Mar 20237:00 amRNSAirijoki Project Soil Geochemical Characterisation
24th Mar 202312:11 pmRNSExploration Update
2nd Feb 202311:05 amRNSIssue of Options
31st Jan 20232:23 pmRNSEspedalen Drill Programme and Director Appointment
30th Nov 20227:00 amRNSExploration Update
2nd Nov 20227:00 amRNSAirijoki Vanadium – Copper Project Update
24th Oct 20221:20 pmRNSExploration Update
30th Sep 20229:21 amRNSInterim Results
13th Sep 202212:28 pmRNSOperational Update
7th Sep 20227:00 amRNSAppointment of Special Advisor to the Board
31st Aug 20227:00 amRNSTotal Voting Rights
23rd Aug 202212:10 pmRNSResult of AGM
16th Aug 20227:00 amRNSHolding(s) in Company
12th Aug 20229:47 amRNSExercise of option over Norwegian Projects
29th Jul 202211:00 amRNSNotice of Annual General Meeting
29th Jun 20226:22 pmRNSAnnual Financial Report
16th May 20227:00 amRNSExercise of option over Norwegian Projects
6th May 20227:00 amRNSAdmission to Main Market and Fundraise
19th Jan 20119:01 amRNSResult of EGM/Cancellation of Admission
22nd Dec 20107:00 amRNSProposed Delisting on AIM
13th Sep 20107:00 amRNSHalf Yearly Report
28th Jul 20101:14 pmRNSResult of AGM
13th Jul 20107:00 amRNSLoan Facility
30th Jun 20104:28 pmRNSAnnual Financial Report
21st Jun 20107:00 amRNSIssue of Equity and Update on Contract
11th May 20107:00 amRNSPreliminary Results
8th Apr 20102:43 pmRNSResult of EGM
22nd Mar 20107:00 amRNSUpdate on Singapore Land Transport Contracts
3rd Nov 200911:00 amRNSIssue of Equity
16th Sep 20097:00 amRNSHalf Yearly Report
31st Jul 20091:46 pmRNSResult of AGM
20th May 20099:50 amRNSChange of Nominated Adviser Name
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.